AI in Mental Health Market Report Scope & Overview:
AI in Mental Health Market was valued at USD 1.30 billion in 2025 and is expected to reach USD 14.90 billion by 2035, growing at a CAGR of 27.62% from 2026-2035.
The Mental Health AI Market is growing exponentially due to the rising awareness regarding mental health conditions, increased demand for efficient mental health care, and technological developments in AI. Utilization of AI technology for the diagnosis, monitoring, and treatment of mental disorders through chatbot services, predictive analysis, and online virtual therapy is now common practice. According to WHO estimates, 970 million people across the globe suffered from some form of mental health disorder in 2019, and hence there is great potential in the area of mental health AI due to the rising prevalence of mental health disorders. Growth in telemedicine offerings, need for discrete mental health treatment facilities, and shortage of professional mental health providers drives the adoption of AI technologies.
Based on the data provided from industry, the Software segment represented about 78.02% market share in 2025, thanks to the extensive use of artificial intelligence-powered apps for mental well-being, chatbots, and digital tools for self-evaluation and therapy — with scalability, affordability, and smartphone availability as key factors behind the predominance of software in AI mental healthcare.
AI in Mental Health Market Size and Forecast
-
Market Size in 2025: USD 1.30 Billion
-
Market Size by 2035: USD 14.90 Billion
-
CAGR: 27.62% from 2026 to 2035
-
Base Year: 2025
-
Forecast Period: 2026-2035
-
Historical Data: 2022-2024

To Get More Information On AI in Mental Health Market - Request Free Sample Report
AI in Mental Health Market Trends
-
The swift implementation of large language models (LLMs) and generative artificial intelligence in mental health chatbots and virtual therapists facilitating complex, compassionate, and medically sound conversations in addressing anxiety, depression, and PTSD.
-
The rapid advancement of artificial intelligence-based clinical decision-making support solutions that aid clinicians in detecting vulnerable individuals, optimizing treatment plans, and anticipating treatment outcomes with longitudinal patient data.
-
The increasing utilization of passive sensing technologies along with wearable devices for mental health monitoring through smartphone accelerometer activity, GPS data, voice, and heart rate variability metrics.
-
The growing incorporation of AI-based mental health solutions within primary care organizations, workplace wellness initiatives, and educational institutions, where insurers, corporations, and academic institutions are investing in preventive mental healthcare infrastructure.
-
Growing prevalence of the use of artificial intelligence technologies in identifying potential mental health problems and forecasting suicides by utilizing the natural language processing of clinicians' reports, social media statistics, and behavior markers for early intervention.
-
The rising maturity of regulation of digital therapeutic treatments in the mental health domain that sees the approval of prescription digital treatments by the FDA for disorders such as anxiety, depression, and insomnia as an opening for AI-powered mental health solutions.
-
The growing trend of adoption of stratified AI care systems that categorize individuals depending on their disorders, choices, and responsiveness to treatment into categories such as self-care digital treatments, AI-coached treatment, telemedicine, and clinic-based treatments.
U.S. AI in Mental Health Market was valued at USD 0.49 billion in 2025 and is expected to reach USD 5.36 billion by 2035, registering a CAGR of 27.02% during 2026-2035.
The United States has a dominant position in the global market for AI mental well-being. This is due to its advanced healthcare infrastructure, the high percentage of people with mental well-being disorders living in the nation, which stands at around 26% of Americans above 18 years old having been diagnosed with at least one mental illness annually, and substantial investments from venture capitalists in the area of digital mental well-being. The increase in the adoption of AI therapies through popular telemedicine platforms including Talkspace, Brightside, and Headspace, along with higher coverage of digital therapies by insurance companies, is fueling the growth of the market quite rapidly. The AI-driven technology for preparing for sessions called Insights was launched by Talkspace in January 2025.
The changes in the U.S. 2025 policy landscape – the new administration issued guidelines to eliminate AI development obstacles and maintain the U.S.'s dominance in AI – will boost investments in AI-based mental well-being applications among private corporations, facilitate FDA approvals for digital therapeutics, and facilitate wider adoption of AI-driven mental well-being platforms in U.S. hospitals and healthcare centers.

AI in Mental Health Market Segment Insights
-
Based on Component, Software accounted for the largest market share (~78.02%) in 2025; Services expected to be the fastest-growing segment.
-
Based on Technology, NLP accounted for the largest market share (~41.3%) in 2025; Machine Learning expected to be the fastest-growing segment.
-
Based on Disorder, Anxiety accounted for the largest market share (~32.8%) in 2025; Schizophrenia expected to be the fastest-growing segment during the forecast period.
AI in Mental Health Market Segment Analysis
By Component, Software dominates, Services expected to grow fastest
The software category captured 78.02% revenue share of AI in mental health in 2025 due to rising usage of AI mental health software, chatbots, and digital portals for self-assessment, monitoring, and delivering cognitive behavioral therapy services. Software solutions are scalable and cost-efficient and can be accessed from smartphones and online platforms – which makes them an ideal option for wellness applications in consumers and employees. Availability of CBT applications, AI-driven mental wellness assistants, and analysis solutions have made software solutions the leading mode of delivery of AI mental health solutions.
The services category would witness the highest CAGR during 2026-2035 as there would be a surge in demand for integrated and personalized mental healthcare assistance using telehealth services augmented with AI, implementation support services in healthcare organizations adopting AI solutions for mental health treatment, and managed mental healthcare services. Need for professional assistance in delivering AI mental health care services has been on the rise and continues to fuel growth in services market segment.

By Technology, NLP dominates, Machine Learning expected to grow fastest
Natural Language Processing (NLP) Market Segment Dominated the Market in 2025, Holding About 41.3% Market Share. Such leadership might be associated with the relevance of NLP technology for the recognition of emotions exhibited by humans using language communication. NLP is a key element in technologies like chatbots and virtual assistants, which diagnose psychological conditions like mental stress through word selection, tone, and syntax. The technology is especially efficient in the diagnosis of depression, anxiety, and post-traumatic stress disorder and is considered the most developed technology used in commercial mental healthcare applications.
Among all technology segments for the market analysis, the Machine Learning (ML) technology segment will have the highest CAGR between 2026 and 2035 due to the increasing adoption of ML algorithms in predictive analytics, personalized therapy, early detection of deterioration in mental illnesses, and clinical decision-making. Machine learning allows for improvements in mental health apps through the analysis of patient data over time.
By Disorder, Anxiety dominates, Schizophrenia expected to grow fastest
Anxiety disorder emerged as the leading market segment in terms of revenue contribution, accounting for around 32.8% in 2025, due to the very high prevalence rate of anxiety disorders in the global population (more than 300 million), along with the proven efficacy of NLP-driven CBT approaches in tackling anxiety disorders' symptoms such as worries, restlessness, and panic attacks through user-friendly digital interventions. The Anxiety & Depression Association of America claims that about 31.9% of individuals between the ages of 13-18 years suffer from anxiety disorders.
The schizophrenia market is projected to record the highest CAGR from 2026 to 2035, on account of groundbreaking developments in AI algorithms that facilitate timely detection of psychosis symptoms, continuous remote monitoring, medication compliance evaluation, and customization of treatments according to patient conditions. The unique ability of AI in dealing with monitoring difficulties in schizophrenia, thanks to passive sensing and voice biomarkers, makes it a promising technology for this market segment.
AI in Mental Health Market Regional Analysis
|
Region |
Major Country |
Share within Region (%) |
|---|---|---|
|
North America |
United States |
42% |
|
Europe |
Germany |
27% |
|
Asia Pacific |
China |
38% |
|
Middle East & Africa |
UAE |
28% |
|
Latin America |
Brazil |
40% |
North America AI in Mental Health Market Insights
North America dominated the AI in mental health market in 2025 with approximately 41.6% market share, driven by strong digital health infrastructure, high prevalence of mental health disorders, significant VC investment in mental health technology, and widespread adoption of AI-enabled therapy platforms among employers, insurers, and healthcare systems. The U.S. accounts for the large majority of regional revenue, supported by large-scale deployments across telehealth platforms and major tech-enabled mental health companies.
Asia Pacific AI in Mental Health Market Insights
The Asia Pacific region is expected to experience the fastest compound annual growth rate (CAGR) of 28.77% during the period from 2026 to 2035, mainly due to growing mental well-being consciousness, increased digital healthcare service adoption, and initiatives by governments in countries like China, India, Japan, and South Korea to improve healthcare infrastructures. There has been a surge in startups in the health technology industry, which use artificial intelligence chatbots and mental well-being apps via mobile devices.
Europe AI in Mental Health Market Insights
Use of AI in Europe is happening in the health sector for psychological treatments due to many benefits like the European Union’s AI Act and Horizon 2020. Countries like the United Kingdom, Germany, and France have implemented the use of AI technology to enhance the effectiveness of mental healthcare services. For instance, the UK’s NHS has adopted AI technology, including Wysa, to treat stress and anxiety conditions.
Middle East & Africa and Latin America AI in Mental Health Market Insights
The Middle East and Latin America are becoming growth regions for AI technology in mental health because of increased awareness regarding mental health issues, increased digitalization, and government investment in the development of their healthcare systems. The use of digital mental health platforms is increasing as cheaper alternatives to inadequate mental health infrastructure.
AI in Mental Health Market Growth Drivers:
Rising Global Mental Health Burden and Digital Care Innovation Accelerating AI in Mental Health Market Growth
AI in the Mental Health Market is experiencing significant growth owing to the rising prevalence of mental disorders across the globe, rising cases of stress-related disorders, and the acute shortage of mental health professionals around the world. Rising need for easily available, cost-effective, and scalable digital mental health offerings is propelling the use of AI-enabled mental therapy platforms, mental wellness assistance applications, and behavioral pattern analysis tools. Developments in large language models, empathic conversational AI, wearable-based passive emotional detection, and clinical decision support tools powered by AI are revolutionizing the delivery of mental healthcare services. Furthermore, growing popularity of telehealth platforms and increased insurance coverage for digital therapies are providing an impetus to commercial uptake. Such developments are facilitating the emergence of AI as a tool for the delivery of mental healthcare services, leading to robust market growth through 2035.
AI in Mental Health Market Restraints
Data Privacy Concerns and Clinical Validation Challenges Restricting Broader AI Adoption
However, AI Mental Health Market is subject to major restraints owing to increasing worries about data privacy of patients, ethical use of AI technology, and clinical validity of AI-assisted mental health diagnosis. The AI mental health solutions store very sensitive emotional, behavioral, and physiological data; hence, there is increased risk of cybersecurity threats and unethical use of data. Besides that, the issue of no standardized validation procedures for clinical efficacy of AI technology, along with issues pertaining to bias in algorithms used for diagnosis, may act as obstacles for both professionals and patients to embrace such technology. Lack of human empathy during AI interactions and internet access required during therapy sessions is yet another challenge.
AI in Mental Health Market Opportunities
AI-Powered Personalized Therapy Platforms and Digital Therapeutics Creating Significant Market Opportunities
The AI in Mental Health Market is creating substantial growth opportunities through the expansion of personalized digital therapy platforms, AI-powered behavioral monitoring systems, and scalable virtual mental healthcare solutions. Increasing integration of AI into telepsychiatry, cognitive behavioral therapy applications, and wearable-based emotional tracking technologies is enabling continuous and personalized mental health support. The rise in adoption of digital therapeutics by healthcare professionals, companies, and insurance firms will provide commercial growth opportunities globally. Furthermore, the progress in the field of generative artificial intelligence, multilingual conversational agents, predictive mental health diagnostics, and emotion detection is making mental health therapy more accessible and personalized than ever before. The wellness initiatives by companies would result in higher uptake and earnings potential from artificial intelligence solutions for mental health through 2035.
Recent Developments:
-
2026: Wysa extended its AI-enabled mental health ecosystem after receiving FDA Breakthrough Device approval for conversational therapies that could incorporate support for anxiety and depression among chronic pain patients.
-
2026: Headspace Health launched an empathic AI-based companion “Ebb” offering triaging features based on AI, aimed at facilitating users towards coaching, therapy, psychiatry, and self-care mental health services.
-
2026: Spring Health announced its intention to acquire Alma to bolster its AI-assisted capabilities of care navigation and matching providers within its employer-oriented wellness ecosystem for mental healthcare.
AI in Mental Health Market Key Players
Some of the AI in Mental Health Market Companies are:
-
Wysa
-
Woebot Health
-
Headspace Health
-
Talkspace
-
BetterHelp
-
Calm
-
Sword Health
-
Spring Health
-
Lyra Health
-
Ginger
-
Quartet Health
-
Brightside Health
-
ieso Digital Health
-
SilverCloud Health
-
Limbic
-
Mindstrong Health
-
Koa Health
-
Innerworld
-
Cerebral
-
Alto Neuroscience
| Report Attributes | Details |
|---|---|
| Market Size in 2025 | USD 1.30 Billion |
| Market Size by 2035 | USD 14.90 Billion |
| CAGR | CAGR of 27.62% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Component (Software, Services, Hardware/Devices) • By Technology (Natural Language Processing, Machine Learning, Deep Learning, Others) • By Disorder (Anxiety, Depression, PTSD, Bipolar Disorder/Schizophrenia, Substance Use Disorders, Others) • By End-Use (Hospitals & Clinics, Individual Consumers, Corporate Wellness, Research Institutes) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
| Company Profiles | Wysa, Woebot Health, Headspace Health, Talkspace, BetterHelp, Calm, Sword Health, Spring Health, Lyra Health, Ginger, Quartet Health, Brightside Health, ieso Digital Health, SilverCloud Health, Limbic, Mindstrong Health, Koa Health, Innerworld, Cerebral, Alto Neuroscience |